Daiichi Sankyo
Kamber Smith is an experienced pharmaceutical sales professional with a strong background in oncology and hematology. Currently serving as a Sr Oncology Territory Manager for Daiichi Sankyo, Inc. since April 2022, Kamber previously held the position of Area Business Manager for Hematology at Sanofi Genzyme, where a significant achievement included launching the company's first oncology product during the Covid-19 pandemic. Earlier roles include notable sales positions at AstraZeneca, Astellas Pharma, Takeda Pharmaceuticals, and Abbott Laboratories, demonstrating a consistent record of top sales performance and successful product launches across various therapeutic areas. Kamber holds a Bachelor’s degree in Accounting from the University of Arkansas.
This person is not in any teams
This person is not in any offices
Daiichi Sankyo
21 followers
Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Daiichi Sankyo Group and Ranbaxy Group. The Daiichi Sankyo Group segment comprises of Daiichi Sankyo Co., Ltd. and its subsidiaries. The Ranbaxy Group segment includes its core company, Ranbaxy Laboratories Ltd. Both group segments deal with business activities in prescription drugs and general pharmaceutical products. The company was founded on September 28, 2005 and is headquartered in Tokyo, Japan.